Glycated Hemoglobin Variability Is Associated With Adverse Outcomes in Patients With Heart Failure Irrespective of Diabetic Status

MLA

Xin Xu, et al. “Glycated Hemoglobin Variability Is Associated With Adverse Outcomes in Patients With Heart Failure Irrespective of Diabetic Status.” Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, vol. 13, no. 9, May 2024. EBSCOhost, https://doi.org/10.1161/JAHA.123.034109.

APA

Xin Xu, Qing‐Wen Ren, Chanchal Chandramouli, Ming‐Yen Ng, Christopher Tze‐Wei Tsang, Yi‐Kei Tse, Xin‐Li Li, Ming‐Ya Liu, Mei‐Zhen Wu, Jia‐Yi Huang, Iok‐Fai Cheang, Jie‐Fu Yang, Fang Wang, Carolyn S.P. Lam, & Kai‐Hang Yiu. (2024). Glycated Hemoglobin Variability Is Associated With Adverse Outcomes in Patients With Heart Failure Irrespective of Diabetic Status. Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 13(9). https://doi.org/10.1161/JAHA.123.034109

Chicago

Xin Xu, Qing‐Wen Ren, Chanchal Chandramouli, Ming‐Yen Ng, Christopher Tze‐Wei Tsang, Yi‐Kei Tse, Xin‐Li Li, et al. 2024. “Glycated Hemoglobin Variability Is Associated With Adverse Outcomes in Patients With Heart Failure Irrespective of Diabetic Status.” Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease 13 (9). doi:10.1161/JAHA.123.034109.